Leon Chen

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Frederic Chereau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leon Chen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 17,500 06 May 2021 Direct
LogicBio Therapeutics, Inc. Director Common Stock 0 $2.01 16 Nov 2022 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 16 Nov 2022 Direct

Insider Reports Filed by Leon Chen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LOGC LogicBio Therapeutics, Inc. 16 Nov 2022 3 $0 4 Director 17 Nov 2022, 20:04
LOGC LogicBio Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 08:00
LOGC LogicBio Therapeutics, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:00
NRIX Nurix Therapeutics, Inc. 06 May 2021 1 $0 4 Director 24 May 2021, 19:48